Literature DB >> 19825979

Mechanoelectrical remodeling and arrhythmias during progression of hypertrophy.

Hongwei Jin1, Elie R Chemaly, Ahyoung Lee, Changwon Kho, Lahouaria Hadri, Roger J Hajjar, Fadi G Akar.   

Abstract

Despite a clear association between left ventricular (LV) mechanical dysfunction in end-stage heart failure and the incidence of arrhythmias, the majority of sudden cardiac deaths occur at earlier stages of disease development. The mechanisms by which structural, mechanical, and molecular alterations predispose to arrhythmias at the tissue level before the onset of LV dysfunction remain unclear. In a rat model of pressure overload hypertrophy (PoH) produced by ascending aortic banding, we correlated mechanical and structural changes measured in vivo with key electrophysiological changes measured ex vivo in the same animals. We found that action potential prolongation, a hallmark of electrical remodeling at the tissue level, is highly correlated with changes in LV wall thickness but not mechanical function. In contrast, conduction delays are not predicted by either mechanical or structural changes during disease development. Moreover, disrupted Cx43 phosphorylation at intermediate (increased) and late (decreased) stages of PoH are associated with moderate and severe conduction delays, respectively. Interestingly, the level of interaction between Cx43 and the cytoskeletal protein ZO-1 is exclusively decreased at the late stage of PoH. Closely coupled action potentials consistent with afterdepolarization-mediated triggered beats were readily observed in 6 of 15 PoH hearts but never in controls. Similarly, PoH (8/15) but not control hearts exhibited sustained episodes of ventricular tachycardia after rapid stimulation. The initiation and early maintenance of arrhythmias in PoH were formed by rapid and highly uniform activation wavefronts emanating from sites distal to the former site of stimulation. In conclusion, repolarization but not conduction delays are predicted by structural remodeling in PoH. Cx43 phosphorylation is disrupted at intermediate (increased) and late (decreased) stages, which are associated with conduction delays. Dephosphorylation of Cx43 is associated with loss of interaction with ZO-1 and severe conduction delays. Remodeling at all stages of PoH predisposes to triggers and focal arrhythmias.

Entities:  

Mesh:

Year:  2009        PMID: 19825979      PMCID: PMC2812033          DOI: 10.1096/fj.09-136622

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  30 in total

1.  Characterization of conduction in the ventricles of normal and heterozygous Cx43 knockout mice using optical mapping.

Authors:  G E Morley; D Vaidya; J Jalife
Journal:  J Cardiovasc Electrophysiol       Date:  2000-03

Review 2.  Mechanisms of remodeling of gap junction distributions and the development of anatomic substrates of arrhythmias.

Authors:  J E Saffitz; R B Schuessler; K A Yamada
Journal:  Cardiovasc Res       Date:  1999-05       Impact factor: 10.787

3.  Ventricular hypertrophy amplifies transmural repolarization dispersion and induces early afterdepolarization.

Authors:  G X Yan; S J Rials; Y Wu; T Liu; X Xu; R A Marinchak; P R Kowey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-11       Impact factor: 4.733

4.  Early onset heart failure in transgenic mice with dilated cardiomyopathy.

Authors:  D G Hall; G E Morley; D Vaidya; M Ard; T R Kimball; S A Witt; M C Colbert
Journal:  Pediatr Res       Date:  2000-07       Impact factor: 3.756

5.  High resolution optical mapping reveals conduction slowing in connexin43 deficient mice.

Authors:  B C Eloff; D L Lerner; K A Yamada; R B Schuessler; J E Saffitz; D S Rosenbaum
Journal:  Cardiovasc Res       Date:  2001-09       Impact factor: 10.787

6.  Novel technique of aortic banding followed by gene transfer during hypertrophy and heart failure.

Authors:  Federica Del Monte; Karyn Butler; Wolfgang Boecker; Judith K Gwathmey; Roger J Hajjar
Journal:  Physiol Genomics       Date:  2002       Impact factor: 3.107

7.  Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43.

Authors:  D E Gutstein; G E Morley; H Tamaddon; D Vaidya; M D Schneider; J Chen; K R Chien; H Stuhlmann; G I Fishman
Journal:  Circ Res       Date:  2001-02-16       Impact factor: 17.367

8.  Echocardiographic assessment of global ventricular function using the myocardial performance index in rats with hypertrophy.

Authors:  Vera M C Salemi; Mara D Pires; Ismar N Cestari; Idágene A Cestari; Michael H Picard; Adolfo A Leirner; Charles Mady
Journal:  Artif Organs       Date:  2004-04       Impact factor: 3.094

9.  Heterogeneous connexin43 expression produces electrophysiological heterogeneities across ventricular wall.

Authors:  Steven Poelzing; Fadi G Akar; Elvera Baron; David S Rosenbaum
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-01-02       Impact factor: 4.733

10.  Impulse conduction and gap junctional remodelling by endothelin-1 in cultured neonatal rat ventricular myocytes.

Authors:  Y Reisner; G Meiry; N Zeevi-Levin; D Y Barac; I Reiter; Z Abassi; N Ziv; S Kostin; J Schaper; M R Rosen; O Binah
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

View more
  23 in total

1.  Altered spatiotemporal dynamics of the mitochondrial membrane potential in the hypertrophied heart.

Authors:  Hongwei Jin; Robert D Nass; Paul J Joudrey; Alexander R Lyon; Elie R Chemaly; Kleopatra Rapti; Fadi G Akar
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

2.  Spatial variability in T-tubule and electrical remodeling of left ventricular epicardium in mouse hearts with transgenic Gαq overexpression-induced pathological hypertrophy.

Authors:  Wen Tao; Jianjian Shi; Gerald W Dorn; Lei Wei; Michael Rubart
Journal:  J Mol Cell Cardiol       Date:  2012-06-21       Impact factor: 5.000

3.  Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension.

Authors:  Benjamin Strauss; Yassine Sassi; Carlos Bueno-Beti; Zeki Ilkan; Nour Raad; Marine Cacheux; Malik Bisserier; Irene C Turnbull; Erik Kohlbrenner; Roger J Hajjar; Lahouaria Hadri; Fadi G Akar
Journal:  J Mol Cell Cardiol       Date:  2018-11-28       Impact factor: 5.000

Review 4.  A multidimensional sight on cardiac failure: uncovered from structural to molecular level.

Authors:  Vijay Urmaliya; Gustavo Franchelli
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

Review 5.  Gene therapies for arrhythmias in heart failure.

Authors:  Fadi G Akar; Roger J Hajjar
Journal:  Pflugers Arch       Date:  2014-02-26       Impact factor: 3.657

6.  Deciphering Arrhythmia Mechanisms - Tools of the Trade.

Authors:  Guy Salama; Fadi G Akar
Journal:  Card Electrophysiol Clin       Date:  2011-03

7.  SK channel enhancers attenuate Ca2+-dependent arrhythmia in hypertrophic hearts by regulating mito-ROS-dependent oxidation and activity of RyR.

Authors:  Tae Yun Kim; Radmila Terentyeva; Karim H F Roder; Weiyan Li; Man Liu; Ian Greener; Shanna Hamilton; Iuliia Polina; Kevin R Murphy; Richard T Clements; Samuel C Dudley; Gideon Koren; Bum-Rak Choi; Dmitry Terentyev
Journal:  Cardiovasc Res       Date:  2017-03-01       Impact factor: 10.787

8.  Biophysical properties and functional consequences of reactive oxygen species (ROS)-induced ROS release in intact myocardium.

Authors:  Nora Biary; Chaoqin Xie; Justin Kauffman; Fadi G Akar
Journal:  J Physiol       Date:  2011-08-08       Impact factor: 5.182

Review 9.  The connexin43 carboxyl terminus and cardiac gap junction organization.

Authors:  Joseph A Palatinus; J Matthew Rhett; Robert G Gourdie
Journal:  Biochim Biophys Acta       Date:  2011-08-09

10.  Glutathione oxidation unmasks proarrhythmic vulnerability of chronically hyperglycemic guinea pigs.

Authors:  Chaoqin Xie; Nora Biary; Carlo G Tocchetti; Miguel A Aon; Nazareno Paolocci; Justin Kauffman; Fadi G Akar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-01       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.